Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-025878

President and CEO acquired 22,501 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
White Marvin L President and CEO 2024-03-02 Option exercise +12,917 57,846 D
White Marvin L President and CEO 2024-03-03 Option exercise +9,584 67,430 D
Derivatives
White Marvin L President and CEO 2024-03-02 Option exercise · Restricted Stock Unit −12,917 25,833 D
White Marvin L President and CEO 2024-03-03 Option exercise · Restricted Stock Unit −9,584 9,584 D
Loading xslF345X05/ownership.xml…